The GeneXpert diagnostic testing technology from the US corporation Cepheid, and its parent company Danaher, has revolutionised rapid, accurate diagnosis of tuberculosis (TB) and other diseases, since entering the market in 2010. Yet, due to the high cost of the GeneXpert test cartridges, many countries are not able to scale up testing for all people who need lifesaving diagnosis and subsequent treatment.
"We are alarmed that the Indian government is trading away our lives and right to health, in the name of a free trade agreement...."
DNP+ was founded in 1999 as a support group of People Living with HIV/AIDS (PLHIV). They actively work towards universal treatment access and provide support services to the PLHIV community.